Electronic nicotine delivery systems

A policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology

Thomas H. Brandon, Maciej L. Goniewicz, Nasser Hanna, Dorothy K. Hatsukami, Roy S. Herbst, Jennifer A. Hobin, Jamie S. Ostroff, Peter G. Shields, Benjamin A. Toll, Courtney A. Tyne, Kasisomayajula Viswanath, Graham W. Warren

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Combustible tobacco use remains the number-one preventable cause of disease, disability, and death in the United States. Electronic nicotine delivery systems (ENDS), which include electronic cigarettes, are devices capable of delivering nicotine in an aerosolized form. ENDS use by both adults and youth has increased rapidly, and some have advocated these products could serve as harm-reduction devices and smoking cessation aids. ENDS may be beneficial if they reduce smoking rates or prevent or reduce the known adverse health effects of smoking. However, ENDS may also be harmful, particularly to youth, if they increase the likelihood that nonsmokers or former smokers will use combustible tobacco products or if they discourage smokers from quitting. The American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO) recognize the potential ENDS have to alter patterns of tobacco use and affect the health of the public; however, definitive data are lacking. The AACR and ASCO recommend additional research on these devices, including assessing the health impacts of ENDS, understanding patterns of ENDS use, and determining what role ENDS have in cessation. Key policy recommendations include supporting federal, state, and local regulation of ENDS; requiring manufacturers to register with the US Food and Drug Administration and report all product ingredients, requiring childproof caps on ENDS liquids, and including warning labels on products and their advertisements; prohibiting youth-oriented marketing and sales; prohibiting child-friendly ENDS flavors; and prohibiting ENDS use in places where cigarette smoking is prohibited.

Original languageEnglish (US)
Pages (from-to)952-963
Number of pages12
JournalJournal of Clinical Oncology
Volume33
Issue number8
DOIs
StatePublished - Mar 10 2015

Fingerprint

Nicotine
Smoking
Tobacco Use
Equipment and Supplies
Harm Reduction
Medical Oncology
Health
Smoking Cessation
United States Food and Drug Administration
Marketing
Research
Tobacco Products
Public Health

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Electronic nicotine delivery systems : A policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology. / Brandon, Thomas H.; Goniewicz, Maciej L.; Hanna, Nasser; Hatsukami, Dorothy K.; Herbst, Roy S.; Hobin, Jennifer A.; Ostroff, Jamie S.; Shields, Peter G.; Toll, Benjamin A.; Tyne, Courtney A.; Viswanath, Kasisomayajula; Warren, Graham W.

In: Journal of Clinical Oncology, Vol. 33, No. 8, 10.03.2015, p. 952-963.

Research output: Contribution to journalArticle

Brandon, TH, Goniewicz, ML, Hanna, N, Hatsukami, DK, Herbst, RS, Hobin, JA, Ostroff, JS, Shields, PG, Toll, BA, Tyne, CA, Viswanath, K & Warren, GW 2015, 'Electronic nicotine delivery systems: A policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology', Journal of Clinical Oncology, vol. 33, no. 8, pp. 952-963. https://doi.org/10.1200/JCO.2014.59.4465
Brandon, Thomas H. ; Goniewicz, Maciej L. ; Hanna, Nasser ; Hatsukami, Dorothy K. ; Herbst, Roy S. ; Hobin, Jennifer A. ; Ostroff, Jamie S. ; Shields, Peter G. ; Toll, Benjamin A. ; Tyne, Courtney A. ; Viswanath, Kasisomayajula ; Warren, Graham W. / Electronic nicotine delivery systems : A policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology. In: Journal of Clinical Oncology. 2015 ; Vol. 33, No. 8. pp. 952-963.
@article{cb4e60eedb664508a1a5faf2140cb052,
title = "Electronic nicotine delivery systems: A policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology",
abstract = "Combustible tobacco use remains the number-one preventable cause of disease, disability, and death in the United States. Electronic nicotine delivery systems (ENDS), which include electronic cigarettes, are devices capable of delivering nicotine in an aerosolized form. ENDS use by both adults and youth has increased rapidly, and some have advocated these products could serve as harm-reduction devices and smoking cessation aids. ENDS may be beneficial if they reduce smoking rates or prevent or reduce the known adverse health effects of smoking. However, ENDS may also be harmful, particularly to youth, if they increase the likelihood that nonsmokers or former smokers will use combustible tobacco products or if they discourage smokers from quitting. The American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO) recognize the potential ENDS have to alter patterns of tobacco use and affect the health of the public; however, definitive data are lacking. The AACR and ASCO recommend additional research on these devices, including assessing the health impacts of ENDS, understanding patterns of ENDS use, and determining what role ENDS have in cessation. Key policy recommendations include supporting federal, state, and local regulation of ENDS; requiring manufacturers to register with the US Food and Drug Administration and report all product ingredients, requiring childproof caps on ENDS liquids, and including warning labels on products and their advertisements; prohibiting youth-oriented marketing and sales; prohibiting child-friendly ENDS flavors; and prohibiting ENDS use in places where cigarette smoking is prohibited.",
author = "Brandon, {Thomas H.} and Goniewicz, {Maciej L.} and Nasser Hanna and Hatsukami, {Dorothy K.} and Herbst, {Roy S.} and Hobin, {Jennifer A.} and Ostroff, {Jamie S.} and Shields, {Peter G.} and Toll, {Benjamin A.} and Tyne, {Courtney A.} and Kasisomayajula Viswanath and Warren, {Graham W.}",
year = "2015",
month = "3",
day = "10",
doi = "10.1200/JCO.2014.59.4465",
language = "English (US)",
volume = "33",
pages = "952--963",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "8",

}

TY - JOUR

T1 - Electronic nicotine delivery systems

T2 - A policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology

AU - Brandon, Thomas H.

AU - Goniewicz, Maciej L.

AU - Hanna, Nasser

AU - Hatsukami, Dorothy K.

AU - Herbst, Roy S.

AU - Hobin, Jennifer A.

AU - Ostroff, Jamie S.

AU - Shields, Peter G.

AU - Toll, Benjamin A.

AU - Tyne, Courtney A.

AU - Viswanath, Kasisomayajula

AU - Warren, Graham W.

PY - 2015/3/10

Y1 - 2015/3/10

N2 - Combustible tobacco use remains the number-one preventable cause of disease, disability, and death in the United States. Electronic nicotine delivery systems (ENDS), which include electronic cigarettes, are devices capable of delivering nicotine in an aerosolized form. ENDS use by both adults and youth has increased rapidly, and some have advocated these products could serve as harm-reduction devices and smoking cessation aids. ENDS may be beneficial if they reduce smoking rates or prevent or reduce the known adverse health effects of smoking. However, ENDS may also be harmful, particularly to youth, if they increase the likelihood that nonsmokers or former smokers will use combustible tobacco products or if they discourage smokers from quitting. The American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO) recognize the potential ENDS have to alter patterns of tobacco use and affect the health of the public; however, definitive data are lacking. The AACR and ASCO recommend additional research on these devices, including assessing the health impacts of ENDS, understanding patterns of ENDS use, and determining what role ENDS have in cessation. Key policy recommendations include supporting federal, state, and local regulation of ENDS; requiring manufacturers to register with the US Food and Drug Administration and report all product ingredients, requiring childproof caps on ENDS liquids, and including warning labels on products and their advertisements; prohibiting youth-oriented marketing and sales; prohibiting child-friendly ENDS flavors; and prohibiting ENDS use in places where cigarette smoking is prohibited.

AB - Combustible tobacco use remains the number-one preventable cause of disease, disability, and death in the United States. Electronic nicotine delivery systems (ENDS), which include electronic cigarettes, are devices capable of delivering nicotine in an aerosolized form. ENDS use by both adults and youth has increased rapidly, and some have advocated these products could serve as harm-reduction devices and smoking cessation aids. ENDS may be beneficial if they reduce smoking rates or prevent or reduce the known adverse health effects of smoking. However, ENDS may also be harmful, particularly to youth, if they increase the likelihood that nonsmokers or former smokers will use combustible tobacco products or if they discourage smokers from quitting. The American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO) recognize the potential ENDS have to alter patterns of tobacco use and affect the health of the public; however, definitive data are lacking. The AACR and ASCO recommend additional research on these devices, including assessing the health impacts of ENDS, understanding patterns of ENDS use, and determining what role ENDS have in cessation. Key policy recommendations include supporting federal, state, and local regulation of ENDS; requiring manufacturers to register with the US Food and Drug Administration and report all product ingredients, requiring childproof caps on ENDS liquids, and including warning labels on products and their advertisements; prohibiting youth-oriented marketing and sales; prohibiting child-friendly ENDS flavors; and prohibiting ENDS use in places where cigarette smoking is prohibited.

UR - http://www.scopus.com/inward/record.url?scp=84924912222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924912222&partnerID=8YFLogxK

U2 - 10.1200/JCO.2014.59.4465

DO - 10.1200/JCO.2014.59.4465

M3 - Article

VL - 33

SP - 952

EP - 963

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 8

ER -